Literature DB >> 11483327

Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations?

J Ma1, H Q Mai, M H Hong, N J Cui, T X Lu, L X Lu, H Y Mo, H Q Min.   

Abstract

PURPOSE: The 5th edition of the American Joint Committee on Cancer (AJCC) staging manual defines new rules for classifying nasopharyngeal carcinoma (NPC). The study was conducted to assess its effectiveness in predicting the prognosis for Chinese patient populations. METHODS AND MATERIALS: Between June 1993 and June 1994, 621 consecutively admitted patients with nondisseminated NPC were treated with definitive-intent radiation therapy alone. All had computed tomography of the nasopharynx, skull base, and the upper neck. A computer database containing all information for staging was formed on presentation. The extent of disease of each patient was restaged according to the 1997 AJCC system.
RESULTS: Of the 621 patients, The 5-year overall survival (OS) rate was 60%. The 1997 AJCC system creates subgroups (Stages I to IV) that are assigned to 38 (6.1%), 270 (43.5%), 157 (25.3%), and 156 (25.1%) patients, respectively. The incidence of parapharyngeal extension was 74.1% (460/621). Of these patients (460) with parapharyngeal extension, 310 (67.4%) patients were classified as T2b disease. The 1997 AJCC system showed highly significant differences between the overall stages for both OS and relapse-free survival (RFS). The 1997 AJCC T classifications showed significant correlation with local failure, and N classification was accurate in predicting FDM. Multivariate analysis showed that paraoropharyngeal involvement was an independently significant prognostic factor for OS, freedom from local recurrence (FLR), and freedom form distant metastasis (FDM).
CONCLUSION: The 1997 AJCC staging system for NPC is prognostically useful for Chinese patient populations. We proposed that subdivision of parapharyngeal extension should be included in future revisions of the staging system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483327     DOI: 10.1016/s0360-3016(01)01537-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  27 in total

1.  Quality of life of nasopharyngeal carcinoma survivors in Mainland China.

Authors:  Yong Wu; Wei-Han Hu; Yun-Fei Xia; Jun Ma; Meng-Zhong Liu; Nian-Ji Cui
Journal:  Qual Life Res       Date:  2006-10-11       Impact factor: 4.147

2.  Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.

Authors:  Huai Liu; Pei-Yu Huang; Lin-Quan Tang; Qiu-Yan Chen; Ying Zhang; Lu Zhang; Ling Guo; Dong-Hua Luo; Hao-Yuan Mo; Yan-Qun Xiang; Fang Qiu; Rui Sun; Ming-Yuan Chen; Yi-Jun Hua; Xing Lv; Lin Wang; Chong Zhao; Xiang Guo; Ka-Jia Cao; Chao-Nan Qian; Ming-Huang Hong; Hai-Qiang Mai
Journal:  Med Oncol       Date:  2013-08-18       Impact factor: 3.064

3.  MEK inhibitor diminishes nasopharyngeal carcinoma (NPC) cell growth and NPC-induced osteoclastogenesis via modulating CCL2 and CXCL16 expressions.

Authors:  Yu Zhu; Chunlin Zou; Zhe Zhang; Chao-Nan Qian; Xin Yang; Junlin Shi; Yudui Xia; Jian Zhang; Yi Lu
Journal:  Tumour Biol       Date:  2015-06-10

4.  A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: Evolving technical choices and survival.

Authors:  S Tonoli; S M Magrini; L Costa; F Paiar; G Simontacchi; V Scotti; N Pasinetti; R Barca; D Barbieri; A De Stefani; E Cellai; M Buglione; G Biti
Journal:  Radiol Med       Date:  2011-11-17       Impact factor: 3.469

5.  miR-135b-5p Targets SIRT1 to Inhibit Deacetylation of c-JUN and Increase MMP7 Expression to Promote Migration and Invasion of Nasopharyngeal Carcinoma Cells.

Authors:  Yali Cheng
Journal:  Mol Biotechnol       Date:  2022-01-30       Impact factor: 2.695

6.  The expression and clinical significance of GPR39 in colon cancer.

Authors:  Xiaoqian Wu; Yingfei Dou; Hankun Xu; Zhichao Jiang
Journal:  Ir J Med Sci       Date:  2021-09-29       Impact factor: 2.089

7.  Long-term results of concurrent chemoradiotherapy for T3/T4 locally advanced nasopharyngeal carcinoma.

Authors:  Can Xiao; Lili Wang; Yang Jiao; Kekang Sun; Songbing Qin; Xiaoting Xu; Jian Guo; Juying Zhou
Journal:  Mol Clin Oncol       Date:  2013-02-05

8.  Influence of gender and age on the survival of patients with nasopharyngeal carcinoma.

Authors:  Guangli Xiao; Yabing Cao; Xibin Qiu; Weihua Wang; Yufeng Wang
Journal:  BMC Cancer       Date:  2013-05-04       Impact factor: 4.430

Review 9.  Emerging treatment options for nasopharyngeal carcinoma.

Authors:  Lu Zhang; Qiu-Yan Chen; Huai Liu; Lin-Quan Tang; Hai-Qiang Mai
Journal:  Drug Des Devel Ther       Date:  2013-02-01       Impact factor: 4.162

10.  Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.

Authors:  Ying Sun; Ling-Long Tang; Lei Chen; Wen-Fei Li; Yan-Ping Mao; Li-Zhi Liu; Ai-Hua Lin; Li Li; Jun Ma
Journal:  BMC Cancer       Date:  2012-02-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.